换一批
换一批
作者：
Jennifer,Cable [1]
;
Barney S,Graham [2]
;
Richard A,Koup [3]
;
Robert A,Seder [3]
;
Katalin,Karikó [4]
;
Norbert,Pardi [5]
;
Dan H,Barouch [6]
;
Bhawna,Sharma [7]
;
Susanne,Rauch [8]
;
Raffael,Nachbagauer [9]
;
Mattias N E,Forsell [10]
;
Michael,Schotsaert [11]
;
Ali H,Ellebedy [9]
;
Karin,Loré [12]
;
Darrell J,Irvine [13]
;
Emily,Pilkington [14]
;
Siri,Tahtinen [15]
;
Elizabeth A,Thompson [16]
;
Yanis,Feraoun [17]
;
Neil P,King [18]
;
Kevin,Saunders [19]
;
Galit,Alter [20]
;
Syed M,Moin [21]
;
Kwinten,Sliepen [22]
;
Gunilla B,Karlsson Hedestam [23]
;
Hedda,Wardemann [24]
;
Bali,Pulendran [17]
;
Nicole A,Doria-Rose [3]
;
Wan-Ting,He [25]
;
Jennifer A,Juno [26]
;
Sila,Ataca [27]
;
Adam K,Wheatley [28]
;
Jason S,McLellan [3]
;
Laura M,Walker [16]
;
Julia,Lederhofer [29]
;
Lisa C,Lindesmith [18]
;
Holger,Wille [3]
;
Peter J,Hotez [18]
;
Linda-Gail,Bekker [30]
作者单位：
PhD Science Writer, New York, New York, USA.
[1]
Morehouse School of Medicine, Atlanta, Georgia, USA.
[2]
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
[3]
BioNTech SE, Mainz, Germany.
[4]
Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
[5]
Harvard Medical School, Boston, Massachusetts, USA.
[6]
Gilead Sciences, Foster City, California, USA.
[7]
CureVac AG, Tübingen, Germany.
[8]
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
[9]
Moderna, Cambridge, Massachusetts, USA.
[10]
Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
[11]
Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, New York, New York, USA.
[12]
Department of Pathology and Immunology; Center for Vaccines and Immunity to Microbial Pathogens; and The Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs, Washington University School of Medicine, St. Louis, Missouri, USA.
[13]
Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
[14]
Koch Institute for Integrative Cancer Research; Department of Biological Engineering; and Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
[15]
Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, California, USA.
[16]
Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.
[17]
Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
[18]
Department of Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia.
[19]
Genentech, South San Francisco, California, USA.
[20]
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
[21]
Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France.
[22]
Department of Biochemistry and Institute for Protein Design, University of Washington, Seattle, Washington, USA.
[23]
Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
[24]
Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
[25]
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
[26]
Division of B Cell Immunology, German Cancer Research Center, Heidelberg, Germany.
[27]
Institute for Immunity, Transplantation and Infection; Department of Pathology; and Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford University, Stanford, California, USA.
[28]
Department of Immunology and Microbiology and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA.
[29]
Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.
[30]
Adimab, LLC, Lebanon, New Hampshire, USA.
[31]
New Hampshire and Adagio Therapeutics, Inc., Waltham, Massachusetts, USA.
[32]
Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
[33]
Centre for Prions and Protein Folding Diseases and Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.
[34]
Texas Children's Center for Vaccine Development, Departments of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, USA.
[35]
James A Baker III Institute for Public Policy, Rice University, Houston, Texas, USA.
[36]
Department of Biology, Baylor University, Waco, Texas, USA.
[37]
Hagler Institute for Advanced Study and Scowcroft Institute of International Affairs, Bush School of Government and Public Service, Texas A&M University, College Station, Texas, USA.
[38]
Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
[39]
DOI
10.1111/nyas.14975
PMID
37020354
发布时间
2024-04-26
- 浏览0
Annals of the New York Academy of Sciences
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
